When big pharma needs intelligence to disrupt markets, they call ESPION.
A pharmaceutical giant was preparing a drug to send shockwaves through the industry when they formulated an alternative drug treatment to their competitors more expensive option. After engagement we embarked on a creative journey to help our client understand the process the other pharmaceutical behemoth (competitor) used, including distribution and sources. Our work had merit in showing the possible reasons as to why the competitor's drug was also causing serious health issues to the patients who were using it. After scathing reports emerged, the competitors stock dropped more than 20%.